Peter de Vries

2.5k total citations
20 papers, 920 citations indexed

About

Peter de Vries is a scholar working on Molecular Biology, Nuclear and High Energy Physics and Biomedical Engineering. According to data from OpenAlex, Peter de Vries has authored 20 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nuclear and High Energy Physics and 6 papers in Biomedical Engineering. Recurrent topics in Peter de Vries's work include Magnetic confinement fusion research (6 papers), Superconducting Materials and Applications (6 papers) and T-cell and B-cell Immunology (4 papers). Peter de Vries is often cited by papers focused on Magnetic confinement fusion research (6 papers), Superconducting Materials and Applications (6 papers) and T-cell and B-cell Immunology (4 papers). Peter de Vries collaborates with scholars based in United States, France and Germany. Peter de Vries's co-authors include Jack W. Singer, Eugene Maraskovsky, Stewart D. Lyman, M P Beckmann, Tim Vanden Bos, Douglas E. Williams, Kathleen S. Picha, Frederick A. Fletcher, Hilary J. McKenna and Ken Brasel and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Peter de Vries

18 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter de Vries United States	11	270	257	245	239	98	20	920
John Burthem United Kingdom	19	234 0.9×	376 1.5×	114 0.5×	266 1.1×	367 3.7×	51	1.2k
Rebecca L. Davis-Harrison United States	13	278 1.0×	309 1.2×	70 0.3×	256 1.1×	238 2.4×	15	843
Monica M. Burdick United States	20	354 1.3×	674 2.6×	425 1.7×	145 0.6×	33 0.3×	48	1.4k
Augusto Rendon United Kingdom	16	104 0.4×	377 1.5×	131 0.5×	228 1.0×	119 1.2×	30	1.0k
Rachel Evans United Kingdom	12	520 1.9×	599 2.3×	193 0.8×	160 0.7×	79 0.8×	18	1.4k
James B. Smadbeck United States	21	88 0.3×	602 2.3×	235 1.0×	196 0.8×	132 1.3×	74	1.2k
Lawrence Lai United States	11	195 0.7×	308 1.2×	381 1.6×	135 0.6×	81 0.8×	12	1.2k
David Kan United States	13	110 0.4×	368 1.4×	322 1.3×	148 0.6×	117 1.2×	22	805
Mohammed M. Dar United States	19	336 1.2×	891 3.5×	820 3.3×	133 0.6×	137 1.4×	42	1.7k
Elliott J. Brea United States	13	253 0.9×	220 0.9×	366 1.5×	60 0.3×	59 0.6×	17	690

Countries citing papers authored by Peter de Vries

Since Specialization

Citations

This map shows the geographic impact of Peter de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter de Vries more than expected).

Fields of papers citing papers by Peter de Vries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter de Vries. The network helps show where Peter de Vries may publish in the future.

Co-authorship network of co-authors of Peter de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Peter de Vries. A scholar is included among the top collaborators of Peter de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter de Vries. Peter de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carannante, G., M. Cavinato, Peter de Vries, et al.. (2023). ITER ECH&CD Control System: Architecture, interfaces and status of development. SHILAP Revista de lepidopterología. 277. 4002–4002. 2 indexed citations

Ravensbergen, T., et al.. (2023). Strategy towards model-based design and testing of the ITER Plasma Control System. Fusion Engineering and Design. 188. 113440–113440. 14 indexed citations

Kulukian, Anita, Patrice Lee, Robert Rosler, et al.. (2020). Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models. Molecular Cancer Therapeutics. 19(4). 976–987. 144 indexed citations

Walker, M.L., Peter de Vries, F. Felici, & Eugenio Schuster. (2020). Introduction to Tokamak Plasma Control. 2901–2918. 18 indexed citations

Walker, M.L., A.S. Welander, David Humphreys, et al.. (2019). Assessment of controllers and scenario control performance for ITER first plasma. Fusion Engineering and Design. 146. 1853–1857. 10 indexed citations

Neu, R., S. Brezinsek, M. Beurskens, et al.. (2014). Experiences With Tungsten Plasma Facing Components in ASDEX Upgrade and JET. IEEE Transactions on Plasma Science. 42(3). 552–562. 25 indexed citations

Baruzzo, M., T. Bolzonella, A. Botrugno, et al.. (2012). MHD instabilities in JET Hybrid Scenario with the ITER Like Wall. Bulletin of the American Physical Society. 54.

Vries, Sjoerd de, et al.. (2011). Quality in E-learning: user experiences in China. University of Twente Research Information. 185–197.

Rosée, Paul La, Taiping Jia, Nicolai Härtel, et al.. (2006). Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib. Clinical Cancer Research. 12(21). 6540–6546. 23 indexed citations

10.

Gong, Baoqing, Feng Hong, Scott A. Jenkins, et al.. (2004). Synthesis, SAR, and antitumor properties of diamino- C , N -diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-β. Bioorganic & Medicinal Chemistry Letters. 14(9). 2303–2308. 23 indexed citations

11.

Singer, Jack W., Brian Baker, Peter de Vries, et al.. (2004). Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate. Advances in experimental medicine and biology. 519. 81–99. 124 indexed citations

12.

Bonham, Lynn, David W. M. Leung, Thayer White, et al.. (2003). Lysophosphatidic acid acyltransferase-β: a novel target for induction of tumour cell apoptosis. Expert Opinion on Therapeutic Targets. 7(5). 643–661. 39 indexed citations

13.

Bonham, Lynn, David W. M. Leung, Thayer White, et al.. (2003). Lysophosphatidic acid acyltransferase-?: a novel target for induction of tumour cell apoptosis. Expert Opinion on Therapeutic Targets. 7(5). 643–661. 1 indexed citations

14.

Schlueter, Annette J., Arthur Μ. Krieg, Peter de Vries, & Xiang Li. (2002). B Cells Express Ly-6C in a Th1 but Not Th2 Cytokine Environment. Journal of Interferon & Cytokine Research. 22(7). 799–806. 8 indexed citations

15.

Schlueter, Annette J., Arthur Μ. Krieg, Peter de Vries, & Xiang Li. (2001). Type I Interferon Is the Primary Regulator of Inducible Ly-6C Expression on T Cells. Journal of Interferon & Cytokine Research. 21(8). 621–629. 20 indexed citations

16.

Schlueter, Annette J., Sudershan K. Bhatia, Xiang Li, et al.. (2001). Delineation among eight major hematopoietic subsets in murine bone marrow using a two-color flow cytometric technique. Cytometry. 43(4). 297–307. 5 indexed citations

17.

Vries, Peter de & Jack W. Singer. (2000). Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents. Experimental Hematology. 28(8). 916–923. 14 indexed citations

18.

Rooij, Gerrit H. de & Peter de Vries. (1999). Efficient Calculation of Solute Transport in Heterogeneous Soils Exhibiting Non‐Richards‐Type Unsaturated Flow. Journal of Environmental Quality. 28(2). 493–497. 5 indexed citations

19.

Lyman, Stewart D., Tim Vanden Bos, Peter de Vries, et al.. (1993). Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell. 75(6). 1157–1167. 444 indexed citations

20.

Vries, Peter de. (1988). Identification of murine haemopoietic stem cells with monoclonal antibodies. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact